George Thanassoulis

McGill University Health Centre — Canada

Medicine · Health Sciences

58h-index12.4kcitations285works7.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(131), Cardiac Valve Diseases and Treatments(70), Diabetes, Cardiovascular Risks, and Lipoproteins(51), Health Systems, Economic Evaluations, Quality of Life(39), Genetic Associations and Epidemiology(23)

Publications281 total

ApoA-1 versus HDL-C as Markers of Cardiovascular Risk
Journal of clinical lipidology·2026Open Access
Race and Ethnic-Specific Burden of Aortic Valve Calcium and Its Association With Long-Term Aortic Stenosis: Multi-Ethnic Study of Atherosclerosis
Circulation Cardiovascular Imaging·2026
Aspirin use, lipoprotein(a), and calcific aortic valve disease: the Multi-ethnic Study of Atherosclerosis
European Heart Journal·2026
Clinical care for patients with elevated lipoprotein(a) in Canada: a practical framework for screening, risk assessment and management.
Canadian Journal of Cardiology·2026
RWD109 Integrating Mendelian Randomization With Real-World Evidence: Cost-Effectiveness of Lipoprotein Testing for Primary Prevention of Cardiovascular Disease in High-Income Countries
Value in Health·2025
Impact of age on aortic valve calcium progression and risk for aortic stenosis: multi-ethnic study of atherosclerosis
European Heart Journal - Cardiovascular Imaging·2025· 1 citedOpen Access
ApoA-1 versus HDL-C as Markers of Cardiovascular Risk
2025Open Access
Aortic Atherosclerosis Detection on Transesophageal Echocardiography is Associated with Left Atrial Appendage Thrombus in Low Thromboembolic Risk Patients
Arrhythmia & Electrophysiology Review·2025Open Access
Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis
Atherosclerosis·2025· 10 citedOpen Access
Myocardial compression and recoil as determinants of coronary blood flow
European Heart Journal·2025· 1 citedOpen Access
Rationale for the routine screening of Lipoprotein(a) in cardiovascular risk assessment
European Journal of Preventive Cardiology·2025· 4 citedOpen Access
ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk
Journal of clinical lipidology·2025· 7 cited
ApoB and Lp(a): core measures to assess cardiovascular risk
European Heart Journal·2025· 5 cited
The Brussels International Declaration on Lipoprotein(a) Testing and Management
Atherosclerosis·2025· 44 citedOpen Access
Lp(a): A Clinical Review
Clinical Biochemistry·2025· 4 cited
REGULAR ASPIRIN USE, LIPOPROTEIN(A), LDL-CHOLESTEROL AND INCIDENT AORTIC VALVE CALCIUM: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS
Journal of the American College of Cardiology·2025Open Access
ROLE OF CARDIAC BIOMARKERS AND AORTIC VALVE CALCIUM IN PREDICTING AORTIC STENOSIS
Journal of the American College of Cardiology·2025Open Access
Plasma Proteomic Assessment of Calcific Aortic Valve Disease in Older Adults
Journal of the American Heart Association·2025· 3 citedOpen Access
A Multidisciplinary Aortopathy Clinic: The McGill Experience
CJC Open·2025Open Access
Hemoglobin A1c and abdominal obesity as predictors of diabetes and ASCVD in individuals with prediabetes in UK Biobank: a prospective observational study
Cardiovascular Diabetology·2024· 4 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

Christopher J. O’Donnell(11), Allan D. Sniderman(8), Ramachandran S. Vasan(8), Michael Pencina(7), James C. Engert(7), Wendy S. Post(6), Patrick Couture(5), J. G. Smith(5), Matthew J. Budoff(5), Joseph M. Massaro(5), Line Dufresne(5), Gina M. Peloso(4), Jerome I. Rotter(4), Vilmundur Guðnason(4), Louise Pilote(4), Udo Hoffmann(4), Ken Williams(4), Jacques Genest(3), Robert A. Hegele(3), Ruth McPherson(3)